The company’s net profit declined by 7.97% to Rs 19.04 for the quarter ended June 30, 2011 against Rs 20.69 crore in the same period previous fiscal. Total income of the company rose to Rs 182.56 crore for the June quarter, as against Rs 163.21 crore in the same period previous fiscal.

Recently, JBCPL board has granted its approval to the company for entering into a definitive agreement to sell its Russia-CIS prescription products business to Dr Reddy’s Laboratories (DRL). The transaction which involves the sale of products registration, intellectual properties, etc is for the consideration worth Rs 137.5 crore.

JB Chem & Pharma Share Price

1841.00 -59.75 (-3.14%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×